NTRK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NMY6 | Y24 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | VHEILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEt |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00170 | Y202 | Sugiyama | AIP XAP2 | IHQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPE |
| O00170 | Y203 | Sugiyama | AIP XAP2 | HQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPEW |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00233 | Y41 | Sugiyama | PSMD9 | SDVQELMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEG |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00401 | Y256 | Sugiyama | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14579 | Y304 | Sugiyama | COPE | HPFIKEYQAKENDFDRLVLQyAPsA________________ |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14828 | Y35 | Sugiyama | SCAMP3 C1orf3 PROPIN1 | sELDNPFQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEP |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15234 | Y240 | Sugiyama | CASC3 MLN51 | HDKFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRK |
| O15234 | Y242 | Sugiyama | CASC3 MLN51 | KFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRKPR |
| O15357 | Y190 | Sugiyama | INPPL1 SHIP2 | AAESAPNGLSTVSHDYLKGsyGLDLEAVRGGASHLPHLTRT |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43448 | Y311 | Sugiyama | KCNAB3 KCNA3B | LITSKYDGRVPDTCRASIKGyQWLKDKVQSEDGKKQQAKVM |
| O43559 | Y417 | SIGNOR|iPTMNet|EPSD | FRS3 | PRVFNFDFRRPGPEPPRQLNyIQVELKGWGGDRPKGPQNPs |
| O43559 | Y455 | SIGNOR|iPTMNet|EPSD | FRS3 | NPsSPQAPMPTTHPARSSDSyAVIDLKKTVAMSNLQRALPR |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y906 | Sugiyama | ACTN4 | yQGPDAVPGALDyKsFStALyGEsDL_______________ |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43813 | Y10 | Sugiyama | LANCL1 GPR69A | ___________MAQRAFPNPyADyNKsLAEGyFDAAGRLTP |
| O43813 | Y13 | Sugiyama | LANCL1 GPR69A | ________MAQRAFPNPyADyNKsLAEGyFDAAGRLTPEFS |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60934 | Y679 | Sugiyama | NBN NBS NBS1 P95 | FRSLVIKNSTSRNPSGINDDyGQLKNFKKFKKVTYPGAGKL |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75390 | Y345 | Sugiyama | CS | DEKLRDYIWNtLNSGRVVPGyGHAVLRKTDPRYTCQREFAL |
| O75683 | Y10 | Sugiyama | SURF6 SURF-6 | ___________MASLLAKDAyLQsLAKKICSHsAPEQQART |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95365 | Y351 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | GAAAGDsDEEsRADDKGVMDyyLKYFSGAHDGDVYPAWSQK |
| O95365 | Y352 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | AAAGDsDEEsRADDKGVMDyyLKYFSGAHDGDVYPAWSQKV |
| O95456 | Y287 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | PQSTEILKKLMTTNEIQsNIyt___________________ |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O96019 | T67 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | RDDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsP |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04181 | Y50 | Sugiyama | OAT | TKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05067 | Y762 | GPS6 | APP A4 AD1 | VtPEERHLSKMQQNGyENPtyKFFEQMQN____________ |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06899 | Y38 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y24 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | VHEILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEt |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07437 | Y59 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDsVRsG |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07686 | Y550 | Sugiyama | HEXB HCC7 | TRHRCRMVERGIAAQPLyAGyCNHENM______________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P07900 | Y466 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKE |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T290 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKIKEKyIDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtN |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08621 | Y146 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | yGPIKRIHMVYSKRsGKPRGyAFIEyEHERDMHSAYKHADG |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y91 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | SELTGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLt |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | Y224 | Sugiyama | TUBA3C TUBA2 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11413 | Y322 | Sugiyama | G6PD | NVVLGQYVGNPDGEGEATKGyLDDPTVPRGSTTATFAAVVL |
| P11498 | S122 | Sugiyama | PC | IIKVAKENNVDAVHPGyGFLsERADFAQACQDAGVRFIGPS |
| P11498 | Y118 | Sugiyama | PC | HIPDIIKVAKENNVDAVHPGyGFLsERADFAQACQDAGVRF |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12004 | Y249 | Sugiyama | PCNA | MSADVPLVVEYKIADMGHLKyyLAPKIEDEEGs________ |
| P12004 | Y250 | Sugiyama | PCNA | SADVPLVVEYKIADMGHLKyyLAPKIEDEEGs_________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13667 | Y278 | Sugiyama | PDIA4 ERP70 ERP72 | FRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTLKQVQE |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y247 | Sugiyama | P4HA1 P4HA | LTKKLLELDPEHQRANGNLKyFEyIMAKEKDVNKSASDDQS |
| P13674 | Y250 | Sugiyama | P4HA1 P4HA | KLLELDPEHQRANGNLKyFEyIMAKEKDVNKSASDDQSDQK |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14618 | Y148 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | GtAEVELKKGATLKITLDNAyMEKCDENILWLDYKNICKVV |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15374 | Y137 | Sugiyama | UCHL3 | STLKKFLEEsVsMsPEERARyLENyDAIRVtHEtsAHEGQT |
| P15374 | Y141 | Sugiyama | UCHL3 | KFLEEsVsMsPEERARyLENyDAIRVtHEtsAHEGQTEAPs |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P15924 | Y2159 | Sugiyama | DSP | NSVFLPKDVALARGLIDRDLyRSLNDPRDSQKNFVDPVTKK |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22001 | Y161 | SIGNOR|EPSD|PSP | KCNA3 HGK5 | DPLRNEYFFDRNRPSFDAILyyyQSGGRIRRPVNVPIDIFS |
| P22001 | Y162 | SIGNOR|EPSD|PSP | KCNA3 HGK5 | PLRNEYFFDRNRPSFDAILyyyQSGGRIRRPVNVPIDIFSE |
| P22001 | Y163 | SIGNOR|EPSD|PSP | KCNA3 HGK5 | LRNEYFFDRNRPSFDAILyyyQSGGRIRRPVNVPIDIFSEE |
| P22001 | Y499 | EPSD|PSP | KCNA3 HGK5 | IVSNFNYFYHRETEGEEQSQyMHVGSCQHLsssAEELRKAR |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | Y331 | Sugiyama | HNRNPA2B1 HNRPA2B1 | SNYGPMKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRs |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23381 | Y212 | Sugiyama | WARS1 IFI53 WARS WRS | VIQMTDDEKYLWKDLtLDQAysyAVENAKDIIACGFDINKT |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y38 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26639 | T574 | Sugiyama | TARS1 TARS | RYHQCATIQLDFQLPIRFNLtyVsHDGDDKKRPVIVHRAIL |
| P26885 | Y112 | Sugiyama | FKBP2 FKBP13 | GLLGMCEGEKRKLVIPsELGyGERGAPPKIPGGATLVFEVE |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27635 | Y199 | Sugiyama | RPL10 DXS648E QM | DEFEDMVAEKRLIPDGCGVKyIPSRGPLDKWRALHS_____ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P28062 | Y184 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | GMGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGN |
| P28062 | Y185 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGNT |
| P28074 | Y236 | Sugiyama | PSMB5 LMPX MB1 X | RRAIyQATYRDAysGGAVNLyHVREDGWIRVSsDNVADLHE |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30041 | Y89 | Sugiyama | PRDX6 AOP2 KIAA0106 | IALSIDSVEDHLAWSKDINAyNCEEPtEKLPFPIIDDRNRE |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30520 | Y428 | Sugiyama | ADSS2 ADSS | WNTDISNARAFKELPVNAQNyVRFIEDELQIPVKWIGVGKs |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31483 | Y10 | Sugiyama | TIA1 | ___________MEDEMPKTLyVGNLSRDVTEALILQLFSQI |
| P31939 | Y290 | Sugiyama | ATIC PURH OK/SW-cl.86 | PAGAAVGIPLsEDEAKVCMVyDLyKTLtPIsAAyARARGAD |
| P31939 | Y293 | Sugiyama | ATIC PURH OK/SW-cl.86 | AAVGIPLsEDEAKVCMVyDLyKTLtPIsAAyARARGADRMs |
| P31943 | Y246 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | AGFERMRRGAYGGGYGGYDDyNGYNDGYGFGSDRFGRDLNy |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S212 | Sugiyama | YWHAB | SLAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtS |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y38 | Sugiyama | H2BC3 H2BFF HIST1H2BB | AITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSK |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34931 | Y547 | Sugiyama | HSPA1L | YKAEDEVQREKIAAKNALEsyAFNMKSVVSDEGLKGKISES |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P34932 | Y660 | Sugiyama | HSPA4 APG2 HSPH2 | VSEDDRNsFtLKLEDTENWLyEDGEDQPKQVYVDKLAELKN |
| P35268 | Y114 | Sugiyama | RPL22 | NNLRDWLRVVANSKESYELRyFQINQDEEEEEDED______ |
| P35579 | Y297 | Sugiyama | MYH9 | FYYLLSGAGEHLKTDLLLEPyNKyRFLsNGHVtIPGQQDKD |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y666 | Sugiyama | STAT1 | DIIRNYKVMAAENIPENPLKyLyPNIDKDHAFGKYYSRPKE |
| P42224 | Y668 | Sugiyama | STAT1 | IRNYKVMAAENIPENPLKyLyPNIDKDHAFGKYYSRPKEAP |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P43490 | Y471 | Sugiyama | NAMPT PBEF PBEF1 | EEYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47712 | Y535 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | sFDDDELDAAVADPDEFERIyEPLDVKSKKIHVVDSGLTFN |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50395 | Y404 | Sugiyama | GDI2 RABGDIB | SDLLVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRM |
| P50402 | Y94 | Sugiyama | EMD EDMD STA | yDLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPS |
| P50402 | Y99 | Sugiyama | EMD EDMD STA | KEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPSRAVRQ |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51511 | Y60 | Sugiyama | MMP15 | LGLGVAAEDAEVHAENWLRLyGYLPQPSRHMSTMRSAQILA |
| P51858 | Y66 | Sugiyama | HDGF HMG1L2 | QVFFFGTHETAFLGPKDLFPyEEsKEKFGKPNKRKGFsEGL |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y64 | Sugiyama | HNRNPM HNRPM NAGR1 | AQNEKRKEKNIKRGGNRFEPyANPtKRYRAFITNIPFDVKW |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52655 | Y365 | Sugiyama | GTF2A1 TF2A1 | SKNKWKFHLKDGIMNLNGRDyIFSKAIGDAEW_________ |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y159 | Sugiyama | PSMA6 PROS27 | ILIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFL |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y216 | Sugiyama | YWHAG | LAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWtsD |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62140 | Y304 | Sugiyama | PPP1CB | VDETLMCSFQILKPSEKKAKyQyGGLNsGRPVtPPRTANPP |
| P62140 | Y306 | Sugiyama | PPP1CB | ETLMCSFQILKPSEKKAKyQyGGLNsGRPVtPPRTANPPKK |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | Y122 | Sugiyama | YWHAE | DVLDKHLIPAANtGEsKVFyyKMKGDYHRyLAEFAtGNDRK |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y20 | Sugiyama | YWHAE | _MDDREDLVyQAKLAEQAERyDEMVESMKKVAGMDVELTVE |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63010 | Y524 | Sugiyama | AP2B1 ADTB2 CLAPB1 | QQVLSLATQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSE |
| P63010 | Y526 | Sugiyama | AP2B1 ADTB2 CLAPB1 | VLSLATQDSDNPDLRDRGyIyWRLLsTDPVTAKEVVLSEKP |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y85 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| P68104 | Y86 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y224 | Sugiyama | TUBA1B | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68366 | Y224 | Sugiyama | TUBA4A TUBA1 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P78318 | Y277 | Sugiyama | IGBP1 IBP1 | AGYPSLPTMTVSDWYEQHRKyGALPDQGIAKAAPEEFRKAA |
| P78406 | Y352 | Sugiyama | RAE1 MRNP41 | YASSYDWSKGHEFyNPQKKNyIFLRNAAEELKPRNKK____ |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P84095 | Y40 | Sugiyama | RHOG ARHG | LICYTTNAFPKEyIPTVFDNySAQsAVDGRTVNLNLWDTAG |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| Q00059 | Y165 | Sugiyama | TFAM TCF6 TCF6L2 | KKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQEKLKTV |
| Q00610 | Y1487 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHELIEF |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01085 | Y12 | Sugiyama | TIAL1 | _________MMEDDGQPRTLyVGNLSRDVTEVLILQLFSQI |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q02487 | Y853 | Sugiyama | DSC2 CDHF2 DSC3 | RLGEKVyLCNQDENHKHAQDyVLTYNYEGRGsVAGsVGCCs |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q02878 | Y116 | Sugiyama | RPL6 TXREB1 | VGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQH |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q07157 | Y1066 | Sugiyama | TJP1 ZO1 | VEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPM |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07960 | Y64 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | sDDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRK |
| Q07960 | Y65 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | DDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRKI |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08380 | Y446 | Sugiyama | LGALS3BP M2BP | RKSQLVYQSRRGPLVKYssDyFQAPSDYRYYPYQSFQTPQH |
| Q10567 | Y524 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | QQVLSLATQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAE |
| Q10567 | Y526 | Sugiyama | AP1B1 ADTB1 BAM22 CLAPB2 | VLSLATQDSDNPDLRDRGyIyWRLLsTDPVAAKEVVLAEKP |
| Q12906 | Y579 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | VEVDGQKFQGAGSNKKVAKAyAALAALEKLFPDtPLALDAN |
| Q12931 | Y498 | Sugiyama | TRAP1 HSP75 HSPC5 | GQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMK |
| Q12931 | Y499 | Sugiyama | TRAP1 HSP75 HSPC5 | QLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMKK |
| Q13162 | Y188 | Sugiyama | PRDX4 | GLGPIRIPLLSDLTHQISKDyGVyLEDSGHTLRGLFIIDDK |
| Q13162 | Y191 | Sugiyama | PRDX4 | PIRIPLLSDLTHQISKDyGVyLEDSGHTLRGLFIIDDKGIL |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13303 | Y270 | Sugiyama | KCNAB2 KCNA2B KCNK2 | IVSGKYDSGIPPYSRAsLKGyQWLKDKILSEEGRRQQAKLK |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13310 | Y291 | Sugiyama | PABPC4 APP1 PABP4 | ERQAELKRKFEQLKQERISRyQGVNLyIKNLDDTIDDEKLR |
| Q13310 | Y297 | Sugiyama | PABPC4 APP1 PABP4 | KRKFEQLKQERISRyQGVNLyIKNLDDTIDDEKLRKEFsPF |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14151 | Y741 | Sugiyama | SAFB2 KIAA0138 | YEQERRPGRRPYDLDRRDDAyWPEGKRVAMEDRYRADFPRP |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14320 | Y53 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | QRIAEENIMKSNIDKKFsAHyDAVEAELKsstVGLVtLNDM |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y293 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | tRHKRTANPsKtIDLGAAAHytGDKAsPDQNAstHtPQssV |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15067 | Y232 | Sugiyama | ACOX1 ACOX | IGTHKPLPGITVGDIGPKFGyDEIDNGyLKMDNHRIPRENM |
| Q15067 | Y239 | Sugiyama | ACOX1 ACOX | PGITVGDIGPKFGyDEIDNGyLKMDNHRIPRENMLMKYAQV |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15287 | Y205 | Sugiyama | RNPS1 LDC2 | GKIKMIDMPVERMHPHLSKGyAyVEFENPDEAEKALKHMDG |
| Q15287 | Y207 | Sugiyama | RNPS1 LDC2 | IKMIDMPVERMHPHLSKGyAyVEFENPDEAEKALKHMDGGQ |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15393 | Y1166 | Sugiyama | SF3B3 KIAA0017 SAP130 | MHLRSEHPPLCGRDHLSFRSyyFPVKNVIDGDLCEQFNsME |
| Q15393 | Y1167 | Sugiyama | SF3B3 KIAA0017 SAP130 | HLRSEHPPLCGRDHLSFRSyyFPVKNVIDGDLCEQFNsMEP |
| Q15417 | Y261 | Sugiyama | CNN3 | STISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEPVI |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15642 | Y590 | Sugiyama | TRIP10 CIP4 STOT STP | MEEDKGDGWTRVRRKEGGEGyVPtsyLRVTLN_________ |
| Q15642 | Y595 | Sugiyama | TRIP10 CIP4 STOT STP | GDGWTRVRRKEGGEGyVPtsyLRVTLN______________ |
| Q16288 | S706 | Sugiyama | NTRK3 TRKC | LVGANLLVKIGDFGMSRDVysTDyyRLFNPSGNDFCIWCEV |
| Q16288 | Y705 | Sugiyama | NTRK3 TRKC | CLVGANLLVKIGDFGMSRDVysTDyyRLFNPSGNDFCIWCE |
| Q16288 | Y709 | Sugiyama | NTRK3 TRKC | ANLLVKIGDFGMSRDVysTDyyRLFNPSGNDFCIWCEVGGH |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16620 | S703 | Sugiyama | NTRK2 TRKB | LVGENLLVKIGDFGMSRDVystDyyRVGGHTMLPIRWMPPE |
| Q16620 | T704 | Sugiyama | NTRK2 TRKB | VGENLLVKIGDFGMSRDVystDyyRVGGHTMLPIRWMPPES |
| Q16620 | Y516 | SIGNOR|iPTMNet|EPSD|PSP | NTRK2 TRKB | GGPDAVIIGMTKIPVIENPQyFGITNSQLKPDTFVQHIKRH |
| Q16620 | Y558 | Sugiyama | NTRK2 TRKB | IVLKRELGEGAFGKVFLAECyNLCPEQDKILVAVKTLKDAS |
| Q16620 | Y702 | GPS6|SIGNOR|EPSD|Sugiyama | NTRK2 TRKB | CLVGENLLVKIGDFGMSRDVystDyyRVGGHTMLPIRWMPP |
| Q16620 | Y706 | GPS6|SIGNOR|EPSD|Sugiyama | NTRK2 TRKB | ENLLVKIGDFGMSRDVystDyyRVGGHTMLPIRWMPPESIM |
| Q16620 | Y707 | GPS6|SIGNOR|EPSD|Sugiyama | NTRK2 TRKB | NLLVKIGDFGMSRDVystDyyRVGGHTMLPIRWMPPESIMY |
| Q16620 | Y817 | GPS6|SIGNOR|EPSD | NTRK2 TRKB | RKNIKGIHTLLQNLAKASPVyLDILG_______________ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y38 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y85 | Sugiyama | EEF1A1P5 EEF1AL3 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| Q5VTE0 | Y86 | Sugiyama | EEF1A1P5 EEF1AL3 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| Q6DN03 | Y38 | Sugiyama | H2BC20P HIST2H2BC | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y38 | Sugiyama | H2BC19P HIST2H2BD | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6FI81 | Y278 | Sugiyama | CIAPIN1 CUA001 PRO0915 | EKEKSREQMSSQPKsACGNCyLGDAFRCAsCPyLGMPAFKP |
| Q6P1L8 | Y51 | Sugiyama | MRPL14 MRPL32 RPML32 | AIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKVGD |
| Q6PEY2 | Y224 | Sugiyama | TUBA3E | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | Y453 | Sugiyama | FIP1L1 FIP1 RHE | HLPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDR |
| Q6UN15 | Y454 | Sugiyama | FIP1L1 FIP1 RHE | LPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDRD |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | Y224 | Sugiyama | TUBA1A TUBA3 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y109 | Sugiyama | SND1 TDRD11 | KLIGKEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVA |
| Q7KZF4 | Y113 | Sugiyama | SND1 TDRD11 | KEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVAEGLA |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7L014 | Y718 | Sugiyama | DDX46 KIAA0801 | NHYEDYVHRAGRTGRAGNKGyAytFITEDQARYAGDIIKAL |
| Q7L014 | Y720 | Sugiyama | DDX46 KIAA0801 | YEDYVHRAGRTGRAGNKGyAytFITEDQARYAGDIIKALEL |
| Q7RTV0 | Y100 | Sugiyama | PHF5A | KDRDGCPKIVNLGSsKTDLFyERKKYGFKKR__________ |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86XP3 | Y573 | Sugiyama | DDX42 | VATDVAARGLDIPSIKTVINyDVARDIDTHTHRIGRTGRAG |
| Q8IWX8 | Y903 | Sugiyama | CHERP DAN26 SCAF6 | YKGVGVALDDPyENyRRNKsysFIARMKARDECK_______ |
| Q8IXH6 | Y211 | Sugiyama | TP53INP2 C20orf110 DOR PINH | RQNRARESRPRRSKNQSsFIyQPCQRQFNY___________ |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y38 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | AVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8WUM4 | Y39 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | KPLVKFIQQTYPSGGEEQAQyCRAAEELSKLRRAAVGRPLD |
| Q8WWM7 | S276 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | MFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRELRA |
| Q8WWM7 | Y270 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | GWDPNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFR |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96BK5 | Y227 | Sugiyama | PINX1 LPTL LPTS | VERKRGKKRNKEATGKDVEsyLQPKAKRHTEGKPERAEAQE |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q99426 | Y107 | Sugiyama | TBCB CG22 CKAP1 | VIDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKR |
| Q99426 | Y114 | Sugiyama | TBCB CG22 CKAP1 | RLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyN |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BQ04 | Y37 | Sugiyama | RBM4B RBM30 | EIRSLFEQYGKVLECDIIKNyGFVHIEDKTAAEDAIRNLHH |
| Q9BQE3 | Y224 | Sugiyama | TUBA1C TUBA6 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BTD8 | Y424 | Sugiyama | RBM42 | FPsFLKAKVIRDKRTGKTKGyGFVSFKDPsDyVRAMREMNG |
| Q9BTD8 | Y435 | Sugiyama | RBM42 | DKRTGKTKGyGFVSFKDPsDyVRAMREMNGKYVGSRPIKLR |
| Q9BWF3 | Y37 | Sugiyama | RBM4 RBM4A | EIRSLFEQYGKVLECDIIKNyGFVHIEDKTAAEDAIRNLHH |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZI7 | Y167 | Sugiyama | UPF3B RENT3B UPF3X | RDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEA |
| Q9C0C2 | Y1122 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | FsPGQQDWsRDFCIEASERsyQFGIIGNDRVsGAGFsPssK |
| Q9GZT8 | Y175 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | PSKAPNyPTEGNHRVEFNVNytQDLDKVMSAVKGIDGVsVT |
| Q9H1E3 | S149 | Sugiyama | NUCKS1 NUCKS JC7 | DsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKEKKM |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H501 | Y72 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | AVDKRGRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQK |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H6T3 | Y88 | Sugiyama | RPAP3 | KAKESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKD |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9HDC5 | Y417 | Sugiyama | JPH1 JP1 | AARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVDAKEN |
| Q9HDC5 | Y423 | Sugiyama | JPH1 JP1 | DIARAVARELsPDFyQPGPDyVKQRFQEGVDAKENPEEKVP |
| Q9NP61 | Y408 | Sugiyama | ARFGAP3 ARFGAP1 | ETVLKTTGYSDRPTARRKPDyEPVENTDEAQKKFGNVKAIs |
| Q9NQ50 | Y199 | Sugiyama | MRPL40 NLVCF URIM | TPPIPNYQPPEGRYNDITKVyTQVEFKR_____________ |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NRX4 | Y116 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AyGPAQHAISTEKIKAKyPDyEVtWANDGy___________ |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NXZ1 | Y340 | Sugiyama | SAGE1 SAGE | QPVIIYLTATGIPGMNTRDQyATITHNVCEERVVNNQPLPS |
| Q9NY12 | Y145 | Sugiyama | GAR1 NOLA1 | FSVKLSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEK |
| Q9NY12 | Y149 | Sugiyama | GAR1 NOLA1 | LSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEKGPPR |
| Q9NY65 | Y224 | Sugiyama | TUBA8 TUBAL2 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9NYF8 | Y219 | Sugiyama | BCLAF1 BTF KIAA0164 | IDEFNKssAtsGDIWPGLsAyDNsPRsPHsPsPIAtPPSQS |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9NYV4 | Y246 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | KWSDSSKQDDsPsGAsYGQDyDLsPsRsHtssNYDsYKKsP |
| Q9P031 | Y97 | Sugiyama | CCDC59 BR22 TAP26 HSPC128 | AQTSLESQFtDRYPDNLKHLyLAEEERHRKQARKVDHPLSE |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y352 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | TEEAREGIKQLLKQGSVQKVyNGLQGY______________ |
| Q9UHX1 | Y269 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | FGKIKSCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNL |
| Q9UHX1 | Y274 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | SCTLARDPTTGKHKGyGFIEyEKAQSSQDAVSSMNLFDLGG |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKK9 | Y198 | Sugiyama | NUDT5 NUDIX5 HSPC115 | LLQRLDALVAEEHLTVDARVySyALALKHANAKPFEVPFLK |
| Q9UKS6 | T209 | Sugiyama | PACSIN3 | QERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQAFE |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9ULF5 | Y596 | Sugiyama | SLC39A10 KIAA1265 ZIP10 | RLNEtELtDLEGQQEsPPKNyLCIEEEKIIDHsHsDGLHtI |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UN86 | T21 | Sugiyama | G3BP2 KIAA0660 | MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSYV |
| Q9UN86 | Y19 | Sugiyama | G3BP2 KIAA0660 | __MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSS |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UQ35 | Y2693 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSS |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y237 | Y71 | Sugiyama | PIN4 | IMEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMV |
| Q9Y247 | Y53 | Sugiyama | FAM50B X5L | QRIAEETILKSQVDKRFSAHyDAVEAELKsstVGLVtLNDM |
| Q9Y262 | Y409 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | QLREKYGDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYD |
| Q9Y262 | Y415 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | GDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPNY |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3F4 | T109 | Sugiyama | STRAP MAWD UNRIP | VSGDELMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDL |
| Q9Y3F4 | Y300 | Sugiyama | STRAP MAWD UNRIP | yAsGSEDGTLRLWQTVVGKtyGLWKCVLPEEDsGELAKPKI |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y4H2 | Y814 | Sugiyama | IRS2 | PLRGVPGCCyssLPRSYKAPytCGGDsDQyVLMssPVGRIL |
| Q9Y4H2 | Y823 | Sugiyama | IRS2 | yssLPRSYKAPytCGGDsDQyVLMssPVGRILEEERLEPQA |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y5S9 | Y96 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | FVTGVHEEATEEDIHDKFAEyGEIKNIHLNLDRRTGYLKGy |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.378331e-08 | 7.132 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.014516e-07 | 6.300 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.546675e-07 | 6.122 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.384191e-06 | 5.623 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.172543e-06 | 5.499 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.849864e-06 | 5.314 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.257260e-06 | 5.371 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.851496e-06 | 5.006 | 1 | 1 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.532011e-06 | 5.021 | 1 | 1 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.251473e-05 | 4.903 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.322038e-05 | 4.879 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.242651e-05 | 4.906 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.487374e-05 | 4.828 | 1 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.797186e-05 | 4.745 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.685429e-05 | 4.773 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.278184e-05 | 4.278 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 7.728197e-05 | 4.112 | 1 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.035693e-04 | 3.985 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.204437e-04 | 3.919 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.410592e-04 | 3.851 | 1 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.402950e-04 | 3.619 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.645946e-04 | 3.577 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.939717e-04 | 3.532 | 1 | 1 |
| Signaling by Leptin | R-HSA-2586552 | 3.033423e-04 | 3.518 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.171784e-04 | 3.380 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.535754e-04 | 3.257 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.278503e-04 | 3.202 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.230907e-04 | 3.205 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.588561e-04 | 3.120 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.067545e-04 | 3.093 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.770528e-04 | 3.110 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.203890e-04 | 3.036 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.017893e-03 | 2.992 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.143438e-03 | 2.942 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.143438e-03 | 2.942 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.145979e-03 | 2.941 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.315224e-03 | 2.881 | 1 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.636063e-03 | 2.786 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.667802e-03 | 2.778 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.212689e-03 | 2.655 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.471037e-03 | 2.607 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 2.871662e-03 | 2.542 | 1 | 1 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.724403e-03 | 2.565 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.005491e-03 | 2.522 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.005491e-03 | 2.522 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.647418e-03 | 2.577 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 3.271201e-03 | 2.485 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.963323e-03 | 2.402 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.838644e-03 | 2.416 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.430143e-03 | 2.354 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.430143e-03 | 2.354 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.305008e-03 | 2.366 | 1 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.430143e-03 | 2.354 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.326458e-03 | 2.274 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.326458e-03 | 2.274 | 1 | 1 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.326458e-03 | 2.274 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.326458e-03 | 2.274 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 5.326458e-03 | 2.274 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.663448e-03 | 2.247 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.898898e-03 | 2.229 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.811377e-03 | 2.167 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.585691e-03 | 2.181 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.404716e-03 | 2.194 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.824675e-03 | 2.166 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.345428e-03 | 2.134 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 9.702661e-03 | 2.013 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 9.702661e-03 | 2.013 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 9.702661e-03 | 2.013 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 9.702661e-03 | 2.013 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 9.702661e-03 | 2.013 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 9.702661e-03 | 2.013 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 9.702661e-03 | 2.013 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 9.702661e-03 | 2.013 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 9.702661e-03 | 2.013 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.803219e-03 | 2.108 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.443063e-03 | 2.025 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.845634e-03 | 2.053 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.875944e-03 | 2.052 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 8.465027e-03 | 2.072 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.080067e-02 | 1.967 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.091698e-02 | 1.962 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.259196e-02 | 1.900 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.259196e-02 | 1.900 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.328524e-02 | 1.877 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.259196e-02 | 1.900 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.364289e-02 | 1.865 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.259196e-02 | 1.900 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.473610e-02 | 1.832 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.510501e-02 | 1.821 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.549384e-02 | 1.810 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.663139e-02 | 1.779 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.627321e-02 | 1.789 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.627321e-02 | 1.789 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.627321e-02 | 1.789 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.627321e-02 | 1.789 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.663139e-02 | 1.779 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.826563e-02 | 1.738 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 1.663139e-02 | 1.779 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.822067e-02 | 1.739 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.785987e-02 | 1.748 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.871363e-02 | 1.728 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.874159e-02 | 1.727 | 0 | 0 |
| Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | R-HSA-5619110 | 1.931177e-02 | 1.714 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.987148e-02 | 1.702 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.158250e-02 | 1.666 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.158250e-02 | 1.666 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.158250e-02 | 1.666 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.323928e-02 | 1.634 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.335243e-02 | 1.632 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.335243e-02 | 1.632 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.882824e-02 | 1.540 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.882824e-02 | 1.540 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.882824e-02 | 1.540 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.882824e-02 | 1.540 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.517998e-02 | 1.599 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.517998e-02 | 1.599 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.682266e-02 | 1.571 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.526488e-02 | 1.597 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.706387e-02 | 1.568 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.900286e-02 | 1.538 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.900286e-02 | 1.538 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.947272e-02 | 1.531 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.947272e-02 | 1.531 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.947272e-02 | 1.531 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.947272e-02 | 1.531 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.947272e-02 | 1.531 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 3.825293e-02 | 1.417 | 1 | 1 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 3.825293e-02 | 1.417 | 1 | 1 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 3.825293e-02 | 1.417 | 1 | 1 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 3.825293e-02 | 1.417 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 3.825293e-02 | 1.417 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.099572e-02 | 1.509 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.099572e-02 | 1.509 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.099572e-02 | 1.509 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 3.728542e-02 | 1.428 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.522020e-02 | 1.453 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.099572e-02 | 1.509 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.170699e-02 | 1.499 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.825293e-02 | 1.417 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.728542e-02 | 1.428 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.170699e-02 | 1.499 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.304122e-02 | 1.481 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.566188e-02 | 1.448 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.065595e-02 | 1.513 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.948177e-02 | 1.404 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.948177e-02 | 1.404 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.150258e-02 | 1.382 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.282238e-02 | 1.368 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.635422e-02 | 1.334 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.635422e-02 | 1.334 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.758675e-02 | 1.323 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.758675e-02 | 1.323 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.758675e-02 | 1.323 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.758675e-02 | 1.323 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.758675e-02 | 1.323 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.758675e-02 | 1.323 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.683055e-02 | 1.245 | 1 | 1 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.344219e-02 | 1.198 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.390401e-02 | 1.194 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.683055e-02 | 1.245 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.127650e-02 | 1.213 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.873581e-02 | 1.312 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.390401e-02 | 1.194 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.390401e-02 | 1.194 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.562782e-02 | 1.255 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.562782e-02 | 1.255 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.227159e-02 | 1.282 | 1 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.683055e-02 | 1.245 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.973270e-02 | 1.303 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.683055e-02 | 1.245 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.613782e-02 | 1.251 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.127650e-02 | 1.213 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.973270e-02 | 1.303 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.562782e-02 | 1.255 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.390401e-02 | 1.194 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.264005e-02 | 1.279 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 5.868744e-02 | 1.231 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.873581e-02 | 1.312 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.613782e-02 | 1.251 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.613782e-02 | 1.251 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.598520e-02 | 1.181 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.598520e-02 | 1.181 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.598520e-02 | 1.181 | 1 | 1 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.598520e-02 | 1.181 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.598520e-02 | 1.181 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.598520e-02 | 1.181 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.598520e-02 | 1.181 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.656900e-02 | 1.177 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.924901e-02 | 1.160 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.200754e-02 | 1.143 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.200754e-02 | 1.143 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.374835e-02 | 1.132 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.505155e-02 | 1.125 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.505155e-02 | 1.125 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.505155e-02 | 1.125 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 7.505155e-02 | 1.125 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.505155e-02 | 1.125 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.505155e-02 | 1.125 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.505155e-02 | 1.125 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.403045e-02 | 1.076 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.292274e-02 | 1.032 | 1 | 1 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 9.292274e-02 | 1.032 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.292274e-02 | 1.032 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.292274e-02 | 1.032 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.292274e-02 | 1.032 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.017292e-01 | 0.993 | 1 | 1 |
| MET receptor recycling | R-HSA-8875656 | 1.017292e-01 | 0.993 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.104508e-01 | 0.957 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.190882e-01 | 0.924 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.190882e-01 | 0.924 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.276422e-01 | 0.894 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.276422e-01 | 0.894 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.276422e-01 | 0.894 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.276422e-01 | 0.894 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.361138e-01 | 0.866 | 1 | 1 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.361138e-01 | 0.866 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.445035e-01 | 0.840 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.445035e-01 | 0.840 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.445035e-01 | 0.840 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.445035e-01 | 0.840 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.445035e-01 | 0.840 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.610410e-01 | 0.793 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.610410e-01 | 0.793 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.691902e-01 | 0.772 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.691902e-01 | 0.772 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.772607e-01 | 0.751 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.087713e-01 | 0.680 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.164597e-01 | 0.665 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.316146e-01 | 0.635 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.316146e-01 | 0.635 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.428002e-01 | 0.845 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.721133e-02 | 1.012 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.691902e-01 | 0.772 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.445035e-01 | 0.840 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.768696e-01 | 0.752 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.445035e-01 | 0.840 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.325892e-01 | 0.877 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.983134e-01 | 0.703 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.983134e-01 | 0.703 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.983134e-01 | 0.703 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.574370e-01 | 0.803 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.276422e-01 | 0.894 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.276422e-01 | 0.894 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.361138e-01 | 0.866 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.361138e-01 | 0.866 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.772607e-01 | 0.751 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.758460e-02 | 1.110 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.087713e-01 | 0.680 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.007953e-01 | 0.697 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.190882e-01 | 0.924 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.931688e-01 | 0.714 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.803459e-01 | 0.744 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.870167e-02 | 1.104 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 1.931688e-01 | 0.714 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.263579e-01 | 0.898 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.528124e-01 | 0.816 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.048805e-02 | 1.094 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.758460e-02 | 1.110 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.758460e-02 | 1.110 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.156953e-02 | 1.038 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.208589e-02 | 1.036 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 9.292274e-02 | 1.032 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.104508e-01 | 0.957 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.276422e-01 | 0.894 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.361138e-01 | 0.866 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.445035e-01 | 0.840 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.852534e-01 | 0.732 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.010079e-01 | 0.697 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.619399e-02 | 1.065 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.316146e-01 | 0.635 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.298793e-01 | 0.639 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.912528e-02 | 1.050 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.208589e-02 | 1.036 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.507499e-02 | 1.022 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.445035e-01 | 0.840 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.240739e-01 | 0.650 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.445035e-01 | 0.840 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.445035e-01 | 0.840 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.610410e-01 | 0.793 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.296088e-01 | 0.887 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.599436e-02 | 1.018 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 9.292274e-02 | 1.032 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.190882e-01 | 0.924 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.190882e-01 | 0.924 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.445035e-01 | 0.840 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.445035e-01 | 0.840 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.445035e-01 | 0.840 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.691902e-01 | 0.772 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.772607e-01 | 0.751 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.087713e-01 | 0.680 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.316146e-01 | 0.635 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.838326e-01 | 0.736 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.120395e-01 | 0.674 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.104508e-01 | 0.957 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.691902e-01 | 0.772 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.240739e-01 | 0.650 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.296088e-01 | 0.887 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.010079e-01 | 0.697 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.403045e-02 | 1.076 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.276422e-01 | 0.894 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.445035e-01 | 0.840 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.445035e-01 | 0.840 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.445035e-01 | 0.840 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.610410e-01 | 0.793 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.691902e-01 | 0.772 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.931688e-01 | 0.714 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.010079e-01 | 0.697 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.394755e-01 | 0.856 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.428002e-01 | 0.845 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.528724e-01 | 0.816 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.528724e-01 | 0.816 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.918766e-01 | 0.717 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.772607e-01 | 0.751 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.852534e-01 | 0.732 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.931688e-01 | 0.714 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.931688e-01 | 0.714 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.032986e-01 | 0.692 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.087713e-01 | 0.680 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.528124e-01 | 0.816 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.276422e-01 | 0.894 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.087713e-01 | 0.680 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.104194e-01 | 0.957 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.768696e-01 | 0.752 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.164597e-01 | 0.665 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.240739e-01 | 0.650 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.240739e-01 | 0.650 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.240739e-01 | 0.650 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.772607e-01 | 0.751 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.010079e-01 | 0.697 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.640469e-01 | 0.785 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.193185e-01 | 0.923 | 1 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.852534e-01 | 0.732 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.240739e-01 | 0.650 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.803459e-01 | 0.744 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.931688e-01 | 0.714 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.316146e-01 | 0.635 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.092963e-01 | 0.961 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.691902e-01 | 0.772 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.010079e-01 | 0.697 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.087713e-01 | 0.680 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.089401e-01 | 0.963 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.593125e-01 | 0.798 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.772607e-01 | 0.751 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.164597e-01 | 0.665 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.316146e-01 | 0.635 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.164597e-01 | 0.665 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.528724e-01 | 0.816 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.010079e-01 | 0.697 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.852534e-01 | 0.732 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.943500e-01 | 0.711 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.329287e-02 | 1.079 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.428002e-01 | 0.845 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 1.803459e-01 | 0.744 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.226912e-01 | 0.911 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.208589e-02 | 1.036 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.347537e-02 | 1.029 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.467917e-01 | 0.833 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.768696e-01 | 0.752 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.596629e-01 | 0.797 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.589609e-02 | 1.066 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.978731e-01 | 0.704 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.017907e-01 | 0.695 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.362459e-01 | 0.627 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.370450e-01 | 0.625 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.390824e-01 | 0.621 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.390824e-01 | 0.621 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.390824e-01 | 0.621 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.390824e-01 | 0.621 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.406326e-01 | 0.619 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.464781e-01 | 0.608 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.464781e-01 | 0.608 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 2.464781e-01 | 0.608 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.464781e-01 | 0.608 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.464781e-01 | 0.608 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.464781e-01 | 0.608 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.465766e-01 | 0.608 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.517689e-01 | 0.599 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.538024e-01 | 0.596 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.538024e-01 | 0.596 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.538024e-01 | 0.596 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.550055e-01 | 0.593 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.586024e-01 | 0.587 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.610560e-01 | 0.583 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.610560e-01 | 0.583 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.610560e-01 | 0.583 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.610560e-01 | 0.583 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.610560e-01 | 0.583 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.610560e-01 | 0.583 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.610560e-01 | 0.583 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.610560e-01 | 0.583 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.622002e-01 | 0.581 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.682395e-01 | 0.571 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.682395e-01 | 0.571 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.682395e-01 | 0.571 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.725304e-01 | 0.565 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.753536e-01 | 0.560 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.753536e-01 | 0.560 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.753536e-01 | 0.560 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.753536e-01 | 0.560 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.753536e-01 | 0.560 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.753536e-01 | 0.560 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 2.753536e-01 | 0.560 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.753536e-01 | 0.560 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 2.753536e-01 | 0.560 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.753536e-01 | 0.560 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 2.801884e-01 | 0.553 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.801884e-01 | 0.553 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.823989e-01 | 0.549 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.823989e-01 | 0.549 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.823989e-01 | 0.549 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.823989e-01 | 0.549 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.823989e-01 | 0.549 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 2.823989e-01 | 0.549 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.823989e-01 | 0.549 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.823989e-01 | 0.549 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.837836e-01 | 0.547 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.893762e-01 | 0.539 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 2.893762e-01 | 0.539 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.893762e-01 | 0.539 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.893762e-01 | 0.539 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.893762e-01 | 0.539 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.909691e-01 | 0.536 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.911450e-01 | 0.536 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.962861e-01 | 0.528 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.962861e-01 | 0.528 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 2.962861e-01 | 0.528 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.962861e-01 | 0.528 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.962861e-01 | 0.528 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.017305e-01 | 0.520 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.031292e-01 | 0.518 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.031292e-01 | 0.518 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.088901e-01 | 0.510 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.099062e-01 | 0.509 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.099062e-01 | 0.509 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.099062e-01 | 0.509 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.099062e-01 | 0.509 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.099062e-01 | 0.509 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.166177e-01 | 0.499 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.166177e-01 | 0.499 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.166177e-01 | 0.499 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 3.166177e-01 | 0.499 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.231643e-01 | 0.491 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.231643e-01 | 0.491 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.232644e-01 | 0.490 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.232644e-01 | 0.490 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.232644e-01 | 0.490 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.247363e-01 | 0.488 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.267220e-01 | 0.486 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.298468e-01 | 0.482 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.298468e-01 | 0.482 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.298468e-01 | 0.482 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.298468e-01 | 0.482 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.313840e-01 | 0.480 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 3.338226e-01 | 0.476 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.363656e-01 | 0.473 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.363656e-01 | 0.473 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.388988e-01 | 0.470 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.428214e-01 | 0.465 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.428214e-01 | 0.465 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.428214e-01 | 0.465 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.428214e-01 | 0.465 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.492147e-01 | 0.457 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.492147e-01 | 0.457 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.584951e-01 | 0.446 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.618167e-01 | 0.442 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.619941e-01 | 0.441 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.654860e-01 | 0.437 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.680264e-01 | 0.434 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.680264e-01 | 0.434 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.680264e-01 | 0.434 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.680264e-01 | 0.434 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.680264e-01 | 0.434 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.680264e-01 | 0.434 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.680264e-01 | 0.434 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.793797e-01 | 0.421 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.802663e-01 | 0.420 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.802663e-01 | 0.420 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.802663e-01 | 0.420 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.802663e-01 | 0.420 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.862795e-01 | 0.413 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.862976e-01 | 0.413 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.862976e-01 | 0.413 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.862976e-01 | 0.413 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.922706e-01 | 0.406 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.922706e-01 | 0.406 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 3.981859e-01 | 0.400 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 3.981859e-01 | 0.400 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.040439e-01 | 0.394 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.098453e-01 | 0.387 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.098453e-01 | 0.387 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.098453e-01 | 0.387 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.155905e-01 | 0.381 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.155905e-01 | 0.381 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.202563e-01 | 0.376 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.202563e-01 | 0.376 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.212802e-01 | 0.375 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.212802e-01 | 0.375 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.212802e-01 | 0.375 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.324949e-01 | 0.364 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.401834e-01 | 0.356 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.401834e-01 | 0.356 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.434937e-01 | 0.353 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.434937e-01 | 0.353 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.434937e-01 | 0.353 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.489133e-01 | 0.348 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.489133e-01 | 0.348 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.489133e-01 | 0.348 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.500072e-01 | 0.347 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.500072e-01 | 0.347 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.511024e-01 | 0.346 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.542806e-01 | 0.343 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.574929e-01 | 0.340 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.586850e-01 | 0.338 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.595959e-01 | 0.338 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.595959e-01 | 0.338 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.595959e-01 | 0.338 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.595959e-01 | 0.338 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.629541e-01 | 0.334 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.648597e-01 | 0.333 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.648597e-01 | 0.333 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.648597e-01 | 0.333 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.648597e-01 | 0.333 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.661632e-01 | 0.331 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.662236e-01 | 0.331 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.700726e-01 | 0.328 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.752351e-01 | 0.323 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.752351e-01 | 0.323 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.752351e-01 | 0.323 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.803475e-01 | 0.318 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.854105e-01 | 0.314 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.854105e-01 | 0.314 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.854105e-01 | 0.314 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.854105e-01 | 0.314 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 4.854105e-01 | 0.314 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.885583e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.904245e-01 | 0.309 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.904245e-01 | 0.309 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.904245e-01 | 0.309 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 4.945290e-01 | 0.306 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.953899e-01 | 0.305 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.953899e-01 | 0.305 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.953899e-01 | 0.305 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.003072e-01 | 0.301 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.003072e-01 | 0.301 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.051769e-01 | 0.297 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.068291e-01 | 0.295 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.147839e-01 | 0.288 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.189349e-01 | 0.285 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.195050e-01 | 0.284 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.199991e-01 | 0.284 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.241887e-01 | 0.281 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.241887e-01 | 0.281 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.247517e-01 | 0.280 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.334207e-01 | 0.273 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.379696e-01 | 0.269 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.424746e-01 | 0.266 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.469358e-01 | 0.262 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.469358e-01 | 0.262 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 5.469358e-01 | 0.262 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 5.469358e-01 | 0.262 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.513539e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.513539e-01 | 0.259 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.540564e-01 | 0.256 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.557291e-01 | 0.255 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.597326e-01 | 0.252 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.597326e-01 | 0.252 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.597326e-01 | 0.252 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.640345e-01 | 0.249 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.640345e-01 | 0.249 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.681024e-01 | 0.246 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.686021e-01 | 0.245 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 5.686021e-01 | 0.245 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.686021e-01 | 0.245 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.686021e-01 | 0.245 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.686021e-01 | 0.245 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.769774e-01 | 0.239 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 5.811043e-01 | 0.236 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 5.811043e-01 | 0.236 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.851912e-01 | 0.233 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.873427e-01 | 0.231 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.892384e-01 | 0.230 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.932465e-01 | 0.227 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.011463e-01 | 0.221 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.011463e-01 | 0.221 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.011463e-01 | 0.221 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.050388e-01 | 0.218 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.088937e-01 | 0.215 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.127111e-01 | 0.213 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.202352e-01 | 0.207 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.213032e-01 | 0.207 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.239426e-01 | 0.205 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.313133e-01 | 0.200 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.348504e-01 | 0.197 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.384161e-01 | 0.195 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.386857e-01 | 0.195 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.389151e-01 | 0.195 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.454438e-01 | 0.190 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.489067e-01 | 0.188 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.489067e-01 | 0.188 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.522207e-01 | 0.186 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.522207e-01 | 0.186 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.523359e-01 | 0.186 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 6.590948e-01 | 0.181 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.590948e-01 | 0.181 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.624251e-01 | 0.179 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.624251e-01 | 0.179 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.624251e-01 | 0.179 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.624305e-01 | 0.179 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.647353e-01 | 0.177 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.657231e-01 | 0.177 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.675099e-01 | 0.176 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.689891e-01 | 0.175 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.689891e-01 | 0.175 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.689891e-01 | 0.175 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 6.760708e-01 | 0.170 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.760708e-01 | 0.170 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.785980e-01 | 0.168 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.817390e-01 | 0.166 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.848494e-01 | 0.164 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.909800e-01 | 0.161 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.909800e-01 | 0.161 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.935619e-01 | 0.159 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.940008e-01 | 0.159 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.956931e-01 | 0.158 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.969921e-01 | 0.157 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.969921e-01 | 0.157 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.969921e-01 | 0.157 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.978120e-01 | 0.156 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.004474e-01 | 0.155 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.028880e-01 | 0.153 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.057930e-01 | 0.151 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.143399e-01 | 0.146 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.171337e-01 | 0.144 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.171337e-01 | 0.144 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.199003e-01 | 0.143 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.199003e-01 | 0.143 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.226400e-01 | 0.141 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.226400e-01 | 0.141 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.280398e-01 | 0.138 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.333352e-01 | 0.135 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.358078e-01 | 0.133 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.410867e-01 | 0.130 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.461296e-01 | 0.127 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.486143e-01 | 0.126 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.505577e-01 | 0.125 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.510748e-01 | 0.124 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.523512e-01 | 0.124 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 7.630232e-01 | 0.117 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.645989e-01 | 0.117 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.653436e-01 | 0.116 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 7.668320e-01 | 0.115 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.676414e-01 | 0.115 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.730247e-01 | 0.112 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 7.765762e-01 | 0.110 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.787993e-01 | 0.109 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.873410e-01 | 0.104 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 7.900645e-01 | 0.102 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.914881e-01 | 0.102 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 7.935315e-01 | 0.100 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.995428e-01 | 0.097 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.015077e-01 | 0.096 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.015077e-01 | 0.096 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.034535e-01 | 0.095 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.053802e-01 | 0.094 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.072883e-01 | 0.093 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.091489e-01 | 0.092 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.129015e-01 | 0.090 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.147363e-01 | 0.089 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.147363e-01 | 0.089 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.165531e-01 | 0.088 | 0 | 0 |
| Translation | R-HSA-72766 | 8.173839e-01 | 0.088 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.182698e-01 | 0.087 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.201339e-01 | 0.086 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.201339e-01 | 0.086 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.233976e-01 | 0.084 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.287849e-01 | 0.082 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.321284e-01 | 0.080 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.370223e-01 | 0.077 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.433278e-01 | 0.074 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.433278e-01 | 0.074 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.478972e-01 | 0.072 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.478972e-01 | 0.072 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 8.508052e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.508697e-01 | 0.070 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.552205e-01 | 0.068 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.566426e-01 | 0.067 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.630139e-01 | 0.064 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.688324e-01 | 0.061 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.691325e-01 | 0.061 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.726622e-01 | 0.059 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.751535e-01 | 0.058 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.770260e-01 | 0.057 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.787999e-01 | 0.056 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.834977e-01 | 0.054 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 8.846436e-01 | 0.053 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.857783e-01 | 0.053 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.869019e-01 | 0.052 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.902072e-01 | 0.051 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.015262e-01 | 0.045 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.024958e-01 | 0.045 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.159515e-01 | 0.038 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.192167e-01 | 0.037 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.200131e-01 | 0.036 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.230136e-01 | 0.035 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.296834e-01 | 0.032 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.345415e-01 | 0.029 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.350473e-01 | 0.029 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.435519e-01 | 0.025 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.479764e-01 | 0.023 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.538195e-01 | 0.021 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.550229e-01 | 0.020 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.649299e-01 | 0.016 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.741197e-01 | 0.011 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.744270e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.760277e-01 | 0.011 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.764661e-01 | 0.010 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.773877e-01 | 0.010 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.796112e-01 | 0.009 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.812984e-01 | 0.008 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.857837e-01 | 0.006 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.874703e-01 | 0.005 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.941420e-01 | 0.003 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.953042e-01 | 0.002 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.975684e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.978863e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.993555e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999998e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.110223e-16 | 15.955 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.110223e-16 | 15.955 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.110223e-16 | 15.955 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.110223e-16 | 15.955 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.110223e-16 | 15.955 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.110223e-16 | 15.955 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.110223e-16 | 15.955 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.110223e-16 | 15.955 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.220446e-16 | 15.654 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.220446e-16 | 15.654 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.330669e-16 | 15.477 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.440892e-16 | 15.353 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.771561e-16 | 15.109 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.992007e-16 | 15.000 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.110223e-15 | 14.955 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.221245e-15 | 14.913 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.443290e-15 | 14.841 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.552714e-15 | 14.449 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.321165e-14 | 13.879 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.409184e-14 | 13.618 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.563816e-14 | 13.448 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.563816e-14 | 13.448 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.707346e-14 | 13.327 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.606626e-14 | 13.251 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.795364e-14 | 13.237 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.306732e-13 | 12.884 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.306732e-13 | 12.884 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.669775e-13 | 12.777 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.854072e-13 | 12.732 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.881828e-13 | 12.725 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.161604e-13 | 12.665 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.443601e-13 | 12.612 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.452483e-13 | 12.610 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.764455e-13 | 12.558 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.623457e-13 | 12.581 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.786660e-13 | 12.555 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.046452e-13 | 12.516 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.895284e-13 | 12.229 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.773782e-13 | 12.109 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.857048e-13 | 12.105 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.086908e-12 | 11.964 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.242229e-12 | 11.906 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.323275e-12 | 11.878 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.323275e-12 | 11.878 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.194245e-12 | 11.659 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.799982e-12 | 11.553 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.799982e-12 | 11.553 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.380629e-12 | 11.471 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.552714e-12 | 11.449 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.402589e-12 | 11.356 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.402589e-12 | 11.356 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.991230e-12 | 11.302 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.628498e-12 | 11.250 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.628498e-12 | 11.250 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.824674e-12 | 11.235 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.030931e-12 | 11.153 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.030931e-12 | 11.153 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.718359e-12 | 11.060 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.081735e-11 | 10.966 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.081735e-11 | 10.966 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.332812e-11 | 10.875 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.486522e-11 | 10.828 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.521061e-11 | 10.818 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.998135e-11 | 10.699 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.998135e-11 | 10.699 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.033351e-11 | 10.692 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.642786e-11 | 10.578 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.562850e-11 | 10.448 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.386025e-11 | 10.269 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.386025e-11 | 10.269 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.947409e-11 | 10.226 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.106815e-11 | 10.214 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.155187e-11 | 10.211 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.316747e-11 | 10.200 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.338030e-11 | 10.134 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.374756e-11 | 10.132 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.670187e-11 | 10.115 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.820888e-11 | 10.107 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.318057e-11 | 10.080 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.033517e-10 | 9.986 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.114447e-10 | 9.953 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.121462e-10 | 9.950 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.191724e-10 | 9.924 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.221242e-10 | 9.913 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.318882e-10 | 9.880 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.326872e-10 | 9.877 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.982345e-10 | 9.703 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.996046e-10 | 9.700 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.996046e-10 | 9.700 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.269493e-10 | 9.644 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.317746e-10 | 9.635 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.703262e-10 | 9.568 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.006049e-10 | 9.522 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.626537e-10 | 9.441 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.651427e-10 | 9.438 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.651427e-10 | 9.438 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.840956e-10 | 9.416 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.229345e-10 | 9.374 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.229345e-10 | 9.374 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.186502e-10 | 9.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.597179e-10 | 9.338 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.488164e-10 | 9.188 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.488164e-10 | 9.188 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.008434e-10 | 9.154 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.452365e-10 | 9.128 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.543133e-10 | 9.068 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.116357e-09 | 8.952 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.116357e-09 | 8.952 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.149301e-09 | 8.940 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.162443e-09 | 8.935 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.272647e-09 | 8.895 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.301138e-09 | 8.886 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.471381e-09 | 8.832 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.521144e-09 | 8.818 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.612663e-09 | 8.792 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.645283e-09 | 8.784 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.757834e-09 | 8.755 | 1 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.112807e-09 | 8.675 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.013608e-09 | 8.696 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.013608e-09 | 8.696 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.013608e-09 | 8.696 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.388476e-09 | 8.622 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.752501e-09 | 8.560 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.908119e-09 | 8.536 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.930607e-09 | 8.533 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.038278e-09 | 8.517 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.330449e-09 | 8.477 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.773422e-09 | 8.423 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.795727e-09 | 8.421 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.841935e-09 | 8.415 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.228075e-09 | 8.374 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.311007e-09 | 8.365 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.311007e-09 | 8.365 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.475669e-09 | 8.349 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.830638e-09 | 8.316 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.040870e-09 | 8.219 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.060958e-09 | 8.094 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.315430e-09 | 8.031 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.455366e-09 | 8.024 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.269873e-08 | 7.896 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.269873e-08 | 7.896 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.346925e-08 | 7.871 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.523268e-08 | 7.817 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.715580e-08 | 7.766 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.742930e-08 | 7.759 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.322730e-08 | 7.634 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.487769e-08 | 7.604 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.811068e-08 | 7.551 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.047024e-08 | 7.516 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.007889e-08 | 7.397 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.789885e-08 | 7.320 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.789885e-08 | 7.320 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.217982e-08 | 7.206 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.217982e-08 | 7.206 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.170559e-08 | 7.144 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.221288e-07 | 6.913 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.354214e-07 | 6.868 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.358640e-07 | 6.867 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.361972e-07 | 6.866 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.409906e-07 | 6.851 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.517704e-07 | 6.819 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.227063e-07 | 6.652 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.774881e-07 | 6.557 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.247052e-07 | 6.489 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.328101e-07 | 6.478 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.330160e-07 | 6.478 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.372236e-07 | 6.472 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.722289e-07 | 6.429 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.805028e-07 | 6.420 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.955841e-07 | 6.403 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.955841e-07 | 6.403 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.955841e-07 | 6.403 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.059669e-07 | 6.296 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.037148e-07 | 6.219 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.111039e-06 | 5.954 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.261687e-06 | 5.899 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.422275e-06 | 5.847 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.494355e-06 | 5.826 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.594465e-06 | 5.797 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.775638e-06 | 5.751 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.694215e-06 | 5.570 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.817259e-06 | 5.550 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.846705e-06 | 5.546 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.381589e-06 | 5.471 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.631996e-06 | 5.440 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.836047e-06 | 5.234 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.644592e-06 | 5.178 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.167989e-06 | 5.038 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.107702e-05 | 4.956 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.109084e-05 | 4.955 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.594152e-05 | 4.797 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.634421e-05 | 4.787 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.708741e-05 | 4.767 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.061770e-05 | 4.686 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.105459e-05 | 4.677 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.117483e-05 | 4.674 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.581003e-05 | 4.446 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.765067e-05 | 4.322 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.507610e-05 | 4.259 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.497860e-05 | 4.187 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.183386e-04 | 3.927 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.255293e-04 | 3.901 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.772872e-04 | 3.751 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.787574e-04 | 3.748 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.586877e-04 | 3.587 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.707173e-04 | 3.567 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.039349e-04 | 3.517 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.207408e-04 | 3.494 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.376536e-04 | 3.472 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.618979e-04 | 3.335 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.940143e-04 | 3.306 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.749513e-04 | 3.240 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.441179e-04 | 3.128 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.484982e-04 | 3.126 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.968967e-04 | 3.099 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.252010e-04 | 3.083 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.208863e-04 | 3.036 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.159975e-03 | 2.936 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.159975e-03 | 2.936 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.165183e-03 | 2.934 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.180153e-03 | 2.928 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.333938e-03 | 2.875 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.514033e-03 | 2.820 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.542109e-03 | 2.812 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.665077e-03 | 2.779 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.969490e-03 | 2.706 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.969490e-03 | 2.706 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.283993e-03 | 2.641 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.522526e-03 | 2.598 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.733807e-03 | 2.563 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.788807e-03 | 2.555 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.788807e-03 | 2.555 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.788807e-03 | 2.555 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.788807e-03 | 2.555 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.976820e-03 | 2.526 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.173318e-03 | 2.498 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.345369e-03 | 2.476 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.817642e-03 | 2.418 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.063577e-03 | 2.391 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.264239e-03 | 2.370 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.349192e-03 | 2.362 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.465191e-03 | 2.350 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.576836e-03 | 2.339 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.228077e-03 | 2.282 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.228077e-03 | 2.282 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.454512e-03 | 2.263 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.466411e-03 | 2.262 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.057441e-03 | 2.218 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.282253e-03 | 2.202 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.424773e-03 | 2.129 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.205195e-03 | 2.036 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.124469e-03 | 2.090 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.653675e-03 | 2.063 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.424773e-03 | 2.129 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.014376e-03 | 2.096 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.738622e-03 | 2.111 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.713887e-03 | 2.173 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.049402e-02 | 1.979 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.050506e-02 | 1.979 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.056328e-02 | 1.976 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.056328e-02 | 1.976 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.056328e-02 | 1.976 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.056328e-02 | 1.976 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.056328e-02 | 1.976 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.056328e-02 | 1.976 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.087727e-02 | 1.963 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.087727e-02 | 1.963 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.136293e-02 | 1.945 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.181402e-02 | 1.928 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.280188e-02 | 1.893 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.283952e-02 | 1.891 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.337121e-02 | 1.874 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.439495e-02 | 1.842 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.496177e-02 | 1.825 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.496177e-02 | 1.825 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.572198e-02 | 1.803 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.721069e-02 | 1.764 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.773513e-02 | 1.751 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.788832e-02 | 1.747 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.838150e-02 | 1.736 | 1 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.845079e-02 | 1.734 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.951634e-02 | 1.710 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.062212e-02 | 1.686 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.329239e-02 | 1.633 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.407975e-02 | 1.618 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.528387e-02 | 1.597 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.688340e-02 | 1.571 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.688340e-02 | 1.571 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.688340e-02 | 1.571 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.734211e-02 | 1.563 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.734211e-02 | 1.563 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.946550e-02 | 1.531 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.969068e-02 | 1.527 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.165246e-02 | 1.500 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.243417e-02 | 1.489 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.264880e-02 | 1.486 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.390142e-02 | 1.470 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.601433e-02 | 1.444 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.621084e-02 | 1.441 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.621084e-02 | 1.441 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.995117e-02 | 1.398 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.040211e-02 | 1.394 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.100505e-02 | 1.387 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.100505e-02 | 1.387 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.155480e-02 | 1.381 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.159212e-02 | 1.381 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.159212e-02 | 1.381 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.159212e-02 | 1.381 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.159212e-02 | 1.381 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.348688e-02 | 1.362 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.348688e-02 | 1.362 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.740834e-02 | 1.324 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.796743e-02 | 1.319 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.861283e-02 | 1.313 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.861283e-02 | 1.313 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.171856e-02 | 1.286 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.171856e-02 | 1.286 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.199331e-02 | 1.284 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.292189e-02 | 1.276 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.394583e-02 | 1.268 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.668656e-02 | 1.247 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.947502e-02 | 1.226 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.947502e-02 | 1.226 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.173862e-02 | 1.209 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.173862e-02 | 1.209 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.165341e-02 | 1.145 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.146404e-02 | 1.089 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.117159e-02 | 1.040 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.117159e-02 | 1.040 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.117159e-02 | 1.040 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.007771e-01 | 0.997 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.102818e-01 | 0.957 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.102818e-01 | 0.957 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.102818e-01 | 0.957 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.196865e-01 | 0.922 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.289924e-01 | 0.889 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.518991e-02 | 1.186 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.289924e-01 | 0.889 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.713658e-02 | 1.113 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.095834e-01 | 0.960 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 7.165341e-02 | 1.145 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.108037e-02 | 1.148 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.950471e-02 | 1.002 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.146404e-02 | 1.089 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.713658e-02 | 1.113 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.146404e-02 | 1.089 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.196865e-01 | 0.922 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.294089e-02 | 1.032 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.196865e-01 | 0.922 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.518991e-02 | 1.186 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.061941e-01 | 0.974 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.007771e-01 | 0.997 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.102818e-01 | 0.957 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.196865e-01 | 0.922 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.289924e-01 | 0.889 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.970868e-02 | 1.047 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.128947e-01 | 0.947 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.366319e-02 | 1.028 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.234147e-01 | 0.909 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.117159e-02 | 1.040 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.196865e-01 | 0.922 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.289924e-01 | 0.889 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.190113e-01 | 0.924 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.030514e-01 | 0.987 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.030514e-01 | 0.987 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.245267e-01 | 0.905 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.146404e-02 | 1.089 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.117159e-02 | 1.040 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 9.117159e-02 | 1.040 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.196865e-01 | 0.922 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.334906e-02 | 1.079 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.289924e-01 | 0.889 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.950471e-02 | 1.002 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.153229e-01 | 0.938 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.165341e-02 | 1.145 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.130639e-01 | 0.947 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.102818e-01 | 0.957 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.225751e-01 | 0.912 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.085981e-01 | 0.964 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.713658e-02 | 1.113 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.119683e-01 | 0.951 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.028342e-01 | 0.988 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.207547e-02 | 1.036 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.850408e-02 | 1.007 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.020330e-01 | 0.991 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.028342e-01 | 0.988 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.061941e-01 | 0.974 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.304817e-01 | 0.884 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.340499e-01 | 0.873 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.340499e-01 | 0.873 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.376400e-01 | 0.861 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.376400e-01 | 0.861 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.382005e-01 | 0.859 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.382005e-01 | 0.859 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.382005e-01 | 0.859 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.382005e-01 | 0.859 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.382005e-01 | 0.859 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.382005e-01 | 0.859 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.382005e-01 | 0.859 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.412512e-01 | 0.850 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.448827e-01 | 0.839 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.473118e-01 | 0.832 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.485336e-01 | 0.828 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.485336e-01 | 0.828 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.485336e-01 | 0.828 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.485336e-01 | 0.828 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.511154e-01 | 0.821 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.522032e-01 | 0.818 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.558906e-01 | 0.807 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.563273e-01 | 0.806 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.563273e-01 | 0.806 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.563273e-01 | 0.806 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.563273e-01 | 0.806 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.563273e-01 | 0.806 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.563273e-01 | 0.806 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 1.563273e-01 | 0.806 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.652481e-01 | 0.782 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.652481e-01 | 0.782 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.652481e-01 | 0.782 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.652481e-01 | 0.782 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 1.708030e-01 | 0.768 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.708030e-01 | 0.768 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.740751e-01 | 0.759 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.740751e-01 | 0.759 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.740751e-01 | 0.759 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.740751e-01 | 0.759 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.819557e-01 | 0.740 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.828093e-01 | 0.738 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.828093e-01 | 0.738 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.828093e-01 | 0.738 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.828093e-01 | 0.738 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.828093e-01 | 0.738 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.828093e-01 | 0.738 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.872536e-01 | 0.728 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.914516e-01 | 0.718 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.914516e-01 | 0.718 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.914516e-01 | 0.718 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.914516e-01 | 0.718 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.935806e-01 | 0.713 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.974157e-01 | 0.705 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.000031e-01 | 0.699 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.000031e-01 | 0.699 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.000031e-01 | 0.699 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.000031e-01 | 0.699 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.051135e-01 | 0.688 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.051135e-01 | 0.688 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.051135e-01 | 0.688 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.084647e-01 | 0.681 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.084647e-01 | 0.681 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.084647e-01 | 0.681 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.084647e-01 | 0.681 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.084647e-01 | 0.681 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.089749e-01 | 0.680 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.128438e-01 | 0.672 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.168373e-01 | 0.664 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.168373e-01 | 0.664 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.206021e-01 | 0.656 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.244902e-01 | 0.649 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.251218e-01 | 0.648 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.251218e-01 | 0.648 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.251218e-01 | 0.648 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.251218e-01 | 0.648 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.322817e-01 | 0.634 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.333192e-01 | 0.632 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.333192e-01 | 0.632 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.333192e-01 | 0.632 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.333192e-01 | 0.632 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.333192e-01 | 0.632 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.361841e-01 | 0.627 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.400901e-01 | 0.620 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.414304e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.414304e-01 | 0.617 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.414304e-01 | 0.617 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.414304e-01 | 0.617 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.469114e-01 | 0.607 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.494563e-01 | 0.603 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.494563e-01 | 0.603 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.494563e-01 | 0.603 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.494563e-01 | 0.603 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.573977e-01 | 0.589 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.573977e-01 | 0.589 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.573977e-01 | 0.589 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.635756e-01 | 0.579 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 2.647961e-01 | 0.577 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.652557e-01 | 0.576 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.652557e-01 | 0.576 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.652557e-01 | 0.576 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.683517e-01 | 0.571 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.705057e-01 | 0.568 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.730309e-01 | 0.564 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.730309e-01 | 0.564 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.730309e-01 | 0.564 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.730309e-01 | 0.564 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.730309e-01 | 0.564 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.733659e-01 | 0.563 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.753290e-01 | 0.560 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.807243e-01 | 0.552 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.807243e-01 | 0.552 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.807243e-01 | 0.552 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.807243e-01 | 0.552 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.807243e-01 | 0.552 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.807243e-01 | 0.552 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.831604e-01 | 0.548 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.877122e-01 | 0.541 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.883368e-01 | 0.540 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.883368e-01 | 0.540 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.883368e-01 | 0.540 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.883368e-01 | 0.540 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.958692e-01 | 0.529 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.958692e-01 | 0.529 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.958692e-01 | 0.529 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.958692e-01 | 0.529 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.958692e-01 | 0.529 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.987987e-01 | 0.525 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.987987e-01 | 0.525 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.027008e-01 | 0.519 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.033223e-01 | 0.518 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.033223e-01 | 0.518 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.033223e-01 | 0.518 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.033223e-01 | 0.518 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.106970e-01 | 0.508 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.106970e-01 | 0.508 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.106970e-01 | 0.508 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.143837e-01 | 0.503 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.179941e-01 | 0.498 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.179941e-01 | 0.498 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.179941e-01 | 0.498 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.179941e-01 | 0.498 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.221492e-01 | 0.492 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.252144e-01 | 0.488 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.252144e-01 | 0.488 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.252144e-01 | 0.488 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.252144e-01 | 0.488 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.323587e-01 | 0.478 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.323587e-01 | 0.478 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.337562e-01 | 0.477 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.394277e-01 | 0.469 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.394277e-01 | 0.469 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.394277e-01 | 0.469 | 0 | 0 |
| Translation | R-HSA-72766 | 3.446940e-01 | 0.463 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.464224e-01 | 0.460 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.464224e-01 | 0.460 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.512364e-01 | 0.454 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.533434e-01 | 0.452 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.533434e-01 | 0.452 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.533434e-01 | 0.452 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.533434e-01 | 0.452 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.533434e-01 | 0.452 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.533434e-01 | 0.452 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.601916e-01 | 0.443 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.601916e-01 | 0.443 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.601916e-01 | 0.443 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.601916e-01 | 0.443 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.601916e-01 | 0.443 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.611505e-01 | 0.442 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.644088e-01 | 0.438 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.644088e-01 | 0.438 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.669676e-01 | 0.435 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.669676e-01 | 0.435 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.669676e-01 | 0.435 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.669676e-01 | 0.435 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.719920e-01 | 0.429 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.736724e-01 | 0.428 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.736724e-01 | 0.428 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.736724e-01 | 0.428 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.736724e-01 | 0.428 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.736724e-01 | 0.428 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.795393e-01 | 0.421 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.803065e-01 | 0.420 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.803065e-01 | 0.420 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.803065e-01 | 0.420 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.803065e-01 | 0.420 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.868707e-01 | 0.412 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.868707e-01 | 0.412 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.868707e-01 | 0.412 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.868707e-01 | 0.412 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.868707e-01 | 0.412 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.868707e-01 | 0.412 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.933658e-01 | 0.405 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.933658e-01 | 0.405 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.933658e-01 | 0.405 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.933658e-01 | 0.405 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.933658e-01 | 0.405 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.933658e-01 | 0.405 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.933658e-01 | 0.405 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.982382e-01 | 0.400 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.982382e-01 | 0.400 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.997925e-01 | 0.398 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.997925e-01 | 0.398 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.997925e-01 | 0.398 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.997925e-01 | 0.398 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.019473e-01 | 0.396 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.019473e-01 | 0.396 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.061515e-01 | 0.391 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.061515e-01 | 0.391 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 4.061515e-01 | 0.391 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.061515e-01 | 0.391 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.061515e-01 | 0.391 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.061515e-01 | 0.391 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.061515e-01 | 0.391 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.124436e-01 | 0.385 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.130096e-01 | 0.384 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.186693e-01 | 0.378 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.197868e-01 | 0.377 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.203286e-01 | 0.376 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.248295e-01 | 0.372 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.248295e-01 | 0.372 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.276012e-01 | 0.369 | 1 | 1 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.303346e-01 | 0.366 | 1 | 1 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.309248e-01 | 0.366 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.309248e-01 | 0.366 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.309248e-01 | 0.366 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.309248e-01 | 0.366 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.309248e-01 | 0.366 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.309248e-01 | 0.366 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.309248e-01 | 0.366 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.309248e-01 | 0.366 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.309248e-01 | 0.366 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.369558e-01 | 0.360 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.369558e-01 | 0.360 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.369558e-01 | 0.360 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.369558e-01 | 0.360 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.369558e-01 | 0.360 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.369558e-01 | 0.360 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.369558e-01 | 0.360 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.420024e-01 | 0.355 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.428943e-01 | 0.354 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.429233e-01 | 0.354 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.488279e-01 | 0.348 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.488279e-01 | 0.348 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.488279e-01 | 0.348 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.546703e-01 | 0.342 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.546703e-01 | 0.342 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.562036e-01 | 0.341 | 1 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.604511e-01 | 0.337 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.604511e-01 | 0.337 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.661710e-01 | 0.331 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.661710e-01 | 0.331 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.667183e-01 | 0.331 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.718307e-01 | 0.326 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.718307e-01 | 0.326 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.718307e-01 | 0.326 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.718307e-01 | 0.326 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.774306e-01 | 0.321 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.774306e-01 | 0.321 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.774306e-01 | 0.321 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.774306e-01 | 0.321 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.829715e-01 | 0.316 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.829715e-01 | 0.316 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.839742e-01 | 0.315 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.907801e-01 | 0.309 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.938475e-01 | 0.306 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.938788e-01 | 0.306 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.938788e-01 | 0.306 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.941620e-01 | 0.306 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.941620e-01 | 0.306 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.992463e-01 | 0.302 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.045572e-01 | 0.297 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.045572e-01 | 0.297 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.075476e-01 | 0.295 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.098121e-01 | 0.293 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.098121e-01 | 0.293 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.149075e-01 | 0.288 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.150117e-01 | 0.288 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.150117e-01 | 0.288 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.201563e-01 | 0.284 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.201563e-01 | 0.284 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.201563e-01 | 0.284 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.252468e-01 | 0.280 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.252468e-01 | 0.280 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.302835e-01 | 0.275 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.336222e-01 | 0.273 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.352671e-01 | 0.271 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.352671e-01 | 0.271 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.352671e-01 | 0.271 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.352671e-01 | 0.271 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.374471e-01 | 0.270 | 1 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.399930e-01 | 0.268 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.401981e-01 | 0.267 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.401981e-01 | 0.267 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.494368e-01 | 0.260 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.499047e-01 | 0.260 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.546813e-01 | 0.256 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.546813e-01 | 0.256 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.546813e-01 | 0.256 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.556572e-01 | 0.255 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.640839e-01 | 0.249 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.640839e-01 | 0.249 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.640839e-01 | 0.249 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.640839e-01 | 0.249 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.648741e-01 | 0.248 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.687109e-01 | 0.245 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.687109e-01 | 0.245 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.687109e-01 | 0.245 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.718035e-01 | 0.243 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.732890e-01 | 0.242 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.778189e-01 | 0.238 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.778189e-01 | 0.238 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.823009e-01 | 0.235 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.918451e-01 | 0.228 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.954652e-01 | 0.225 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.974936e-01 | 0.224 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.997610e-01 | 0.222 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.997610e-01 | 0.222 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.997610e-01 | 0.222 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.997610e-01 | 0.222 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.003670e-01 | 0.222 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 6.040114e-01 | 0.219 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.040114e-01 | 0.219 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.060677e-01 | 0.217 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.060677e-01 | 0.217 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.082169e-01 | 0.216 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.123781e-01 | 0.213 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.205690e-01 | 0.207 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.245997e-01 | 0.204 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.325338e-01 | 0.199 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.325338e-01 | 0.199 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.325338e-01 | 0.199 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.364381e-01 | 0.196 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.403012e-01 | 0.194 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.468724e-01 | 0.189 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.479053e-01 | 0.188 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.516473e-01 | 0.186 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.553497e-01 | 0.184 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.553497e-01 | 0.184 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.590129e-01 | 0.181 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.626375e-01 | 0.179 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.626375e-01 | 0.179 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.697721e-01 | 0.174 | 1 | 1 |
| Collagen formation | R-HSA-1474290 | 6.697721e-01 | 0.174 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.732829e-01 | 0.172 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.732829e-01 | 0.172 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.767567e-01 | 0.170 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.767567e-01 | 0.170 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.767567e-01 | 0.170 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.801937e-01 | 0.167 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.835944e-01 | 0.165 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.842805e-01 | 0.165 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.935822e-01 | 0.159 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.935822e-01 | 0.159 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.968413e-01 | 0.157 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.968413e-01 | 0.157 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.032566e-01 | 0.153 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.064134e-01 | 0.151 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.126272e-01 | 0.147 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.187102e-01 | 0.143 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.187102e-01 | 0.143 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.187102e-01 | 0.143 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.187102e-01 | 0.143 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.217036e-01 | 0.142 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.333636e-01 | 0.135 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.333636e-01 | 0.135 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.472578e-01 | 0.127 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.493868e-01 | 0.125 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.526118e-01 | 0.123 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.526118e-01 | 0.123 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.526118e-01 | 0.123 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.552464e-01 | 0.122 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.629838e-01 | 0.117 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.824485e-01 | 0.107 | 1 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.225404e-01 | 0.085 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.281609e-01 | 0.082 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.299948e-01 | 0.081 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.299948e-01 | 0.081 | 1 | 0 |
| Gastrulation | R-HSA-9758941 | 8.318092e-01 | 0.080 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.353805e-01 | 0.078 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.371377e-01 | 0.077 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.472965e-01 | 0.072 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.568251e-01 | 0.067 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.671970e-01 | 0.062 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.686164e-01 | 0.061 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.857525e-01 | 0.053 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.940394e-01 | 0.049 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.962953e-01 | 0.048 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.980768e-01 | 0.047 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.164960e-01 | 0.038 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.216225e-01 | 0.035 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.241165e-01 | 0.034 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.354516e-01 | 0.029 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.426785e-01 | 0.026 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.589987e-01 | 0.018 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.607355e-01 | 0.017 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.750920e-01 | 0.011 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.870268e-01 | 0.006 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.900131e-01 | 0.004 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.919719e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.920634e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.971958e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.982830e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.992551e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.997909e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.998909e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.000000e+00 | 0.000 | 1 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.000000e+00 | 0.000 | 1 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 1.000000e+00 | 0.000 | 1 | 1 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 1.000000e+00 | 0.000 | 1 | 1 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.000000e+00 | 0.000 | 1 | 1 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 1.000000e+00 | 0.000 | 1 | 1 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
